These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9795924

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB, Hollinger FB.
    Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.
    Yao GB, Fu XX, Tian GS, Xu DZ, Hao LJ, Huangfu YS, Su CX.
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1165-70. PubMed ID: 11106097
    [Abstract] [Full Text] [Related]

  • 5. Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group.
    Heathcote EJ, James S, Mullen KD, Hauser SC, Rosenblate H, Albert DG.
    Hepatology; 1999 Aug; 30(2):562-6. PubMed ID: 10421669
    [Abstract] [Full Text] [Related]

  • 6. Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group.
    Lee WM, Reddy KR, Tong MJ, Black M, van Leeuwen DJ, Hollinger FB, Mullen KD, Pimstone N, Albert D, Gardner S.
    Hepatology; 1998 Nov; 28(5):1411-5. PubMed ID: 9794929
    [Abstract] [Full Text] [Related]

  • 7. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
    Payen JL, Izopet J, Galindo-Migeot V, Lauwers-Cances V, Zarski JP, Seigneurin JM, Dussaix E, Voigt JJ, Selves J, Barange K, Puel J, Pascal JP.
    Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
    [Abstract] [Full Text] [Related]

  • 8. Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group.
    Jensen DM, Krawitt EL, Keeffe EB, Hollinger FB, James SP, Mullen K, Everson GT, Hoefs JC, Fromm H, Black M, Foust RT, Pimstone NR, Heathcote EJ, Albert D.
    Am J Gastroenterol; 1999 Dec; 94(12):3583-8. PubMed ID: 10606323
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis.
    Alavian SM, Behnava B, Tabatabaei SV.
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1071-9. PubMed ID: 20857094
    [Abstract] [Full Text] [Related]

  • 11. Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Consensus Interferon Study Group.
    Pockros PJ, Tong M, Lee WM, van Leeuwen DJ, Keeffe EB, Bala K, Killenberg PG, Foust RT, Rosenblate HJ, Payne KM, Fromm H, Lesesne HR, Black M.
    J Viral Hepat; 1998 Jul; 5(4):271-6. PubMed ID: 9751014
    [Abstract] [Full Text] [Related]

  • 12. Interferon alfacon-1: a novel interferon for the treatment of chronic hepatitis C.
    Alberti A.
    BioDrugs; 1999 Nov; 12(5):343-57. PubMed ID: 18031187
    [Abstract] [Full Text] [Related]

  • 13. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
    Erickson AK, Seiwert S, Gale M.
    Antivir Ther; 2008 Nov; 13(7):851-62. PubMed ID: 19043919
    [Abstract] [Full Text] [Related]

  • 14. Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C.
    Sjogren MH, Sjogren R, Holtzmuller K, Winston B, Butterfield B, Drake S, Watts A, Howard R, Smith M.
    Dig Dis Sci; 2005 Apr; 50(4):727-32. PubMed ID: 15844709
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of consensus interferon in the treatment of chronic hepatitis C.
    Kao JH, Chen PJ, Lai MY, Chen DS.
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1418-23. PubMed ID: 11197053
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T, Tanaka E, Matsumoto A, Urushihara A, Sodeyama T.
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [Abstract] [Full Text] [Related]

  • 17. Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose.
    Shiffman ML, Hofmann CM, Luketic VA, Sanyal AJ, Contos MJ, Mills AS.
    Hepatology; 1996 Jul; 24(1):21-6. PubMed ID: 8707264
    [Abstract] [Full Text] [Related]

  • 18. Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group.
    Keeffe EB, Dusheiko GM, Tong MJ, Hollinger FB, Heathcote EJ, McHutchison J, Albert D.
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):211-6. PubMed ID: 10850385
    [Abstract] [Full Text] [Related]

  • 19. Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.
    Piccinino F, Felaco FM, Sagnelli E, Aprea L, Messina V, Pasquale G, Filippini P, Scolastico C.
    Res Virol; 1998 Dec; 149(5):283-91. PubMed ID: 9879606
    [Abstract] [Full Text] [Related]

  • 20. Consensus interferon for chronic hepatitis C patients with genotype 1 who failed to respond to, or relapsed after, interferon alpha-2b and ribavirin in combination: an Italian pilot study.
    Barbaro G, Barbarini G.
    Eur J Gastroenterol Hepatol; 2002 May; 14(5):477-83. PubMed ID: 11984144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.